Sort by
Refine Your Search
-
Listed
-
Employer
- University of Oxford
- ;
- KINGS COLLEGE LONDON
- Durham University
- UNIVERSITY OF VIENNA
- University of London
- DURHAM UNIVERSITY
- Heriot Watt University
- King's College London
- University of Birmingham
- University of Liverpool
- ; University of Oxford
- Aston University
- St George's University of London
- University of Cambridge
- University of Lincoln
- 6 more »
- « less
-
Field
-
into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. You will hold a relevant PhD/DPhil, together with relevant knowledge in normal and malignant hematopoiesis
-
that reveal new insights into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. This is a unique opportunity to work at the cutting edge of translational
-
to dissect early disease mechanisms and identify potential therapeutic targets for treatment of IPF. Through close links with the Royal Brompton Hospital, there is excellent access to human blood, airway and
-
to dissect early disease mechanisms and identify potential therapeutic targets for treatment of IPF. Through close links with the Royal Brompton Hospital, there is excellent access to human blood, airway and
-
that reveal new insights into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. This is a unique opportunity to work at the cutting edge of translational
-
approaches including targeted genetic murine models, primary cell culture and analysis, multi-omics and bioinformatics. The biological focus will be on vascular biology, immune cell function and metabolism
-
on the project Relational Harm: Targeting the Family in War and Oppression. The PI is Dr Rebekka Friedman, and the project is an ERC-funded Consolidator Grant. The PDRA position is for a 30-months from
-
with different diseases in diverse populations and to identify potential therapeutic targets. This is an exciting opportunity to contribute to a programme of research that assess the causal relevance
-
in cancer and infection, their involvement in preventing immune-mediated pathology in autoimmunity remains poorly understood. Using genetic and antibody-based targeting, we aim to dissect how
-
in preventing immune-mediated pathology in autoimmunity remains poorly understood. Using genetic and antibody-based targeting, we aim to dissect how these pathways modulate T-cell signalling